Traditional Chinese medicine composition for treating weakened body resistance stagnant-heat hepatitis b with hepatic fibrosis

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating weakened body resistance stagnant-heat hepatitis b with hepatic fibrosis. The traditional Chinese medicine composition comprises the following traditional Chinese medicines in parts by weight: 4-8 parts of carex kobomugi ohwi, 5-13 parts of cyananthus incanus Hook. F et Thons., 5-13 parts of aleuritopteris squamosa (Hope et C.H.Wright) ching, 6-14 parts of ficus lyrata, 6-14 parts of radix campanumoeae, 6-14 parts of linaria buriaticaTarcz.etBenth., 6-14 parts of arteimiaisiasieuersianaehrhartexwilld., 4-8 parts of elaeagnus viridis Serv.var. delavayi Lecte., 8-16 parts of brachystemma calycinu D.Don, 6-14 parts of araliaundulatahand.-Mazz, 1-3 parts of meconopsis horridula Hook.f.ex Thoms., and 4-8 parts of liquorice. The traditional Chinese medicines are combined to exert the effect of invigorating spleen and supplementing qi, clearing heat and promoting dieresis, and promoting blood circulation to remove blood stasis, carefully considers the pathogenesis of the weakened body resistance stagnant-heat hepatitis b with hepatic fibrosis, can alleviate clinical symptoms of patients with hepatic fibrosis, can reduce serum AST, ALT and four indicators of hepatic fibrosis, and improves the liver function and hepatic fibrosis degree.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating liver fibrosis caused by deficiency and blood stasis-heat type hepatitis B. Background technique [0002] Hepatic fibrosis (HepatieFibrosisHF) is the liver's repair response to chronic damage, and is a common pathological change in many chronic liver diseases. About 80% of patients in my country are related to chronic hepatitis B virus infection. Professor Han S Poppe, a famous American hepatologist, proposed that "whoever can prevent or delay the occurrence of liver fibrosis will cure most chronic liver diseases". Its reversibility provides a good opportunity for clinical prevention and treatment of liver cirrhosis. Prevention and reversal of liver fibrosis is an important means to delay or prevent the occurrence of liver cirrhosis. [0003] Chronic hepatitis B is a viral infectious disease caused by hepatiti...

AI Technical Summary

Problems solved by technology

[0004] So far, modern medicine still lacks effective drugs for the treatment of chronic liver fibrosis. The reported drugs include interferon, antiviral drugs, liver cell protection drugs, colchicine, penicillamine and more than a dozen drugs. It has a certain curative effect, but due to the large toxicity and side effects, high cost and other reasons, the clinical application is limited.